SLC2A4 and Insulin resistance: Liu et al. found that myricetin (3.0 mg/kg) improved insulin sensitivity and glucose utilization in fructose-fed rats by enhancing insulin receptor substrate-1 (IRS-1) and GLUT4 activity in muscle tissue, reversing insulin resistance and restoring normal insulin signalling [52].